鲁抗医药：关于头孢呋辛酯干混悬剂通过一致性评价的公告

Core Viewpoint - The company, LuKang Pharmaceutical, has received approval from the National Medical Products Administration for its drug, Cefuroxime Axetil Dry Suspension, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The approval notification for the drug was issued on August 13 [1] - The drug is referred to as Cefuroxime Axetil Dry Suspension [1] - The approval indicates that the drug meets the standards for quality and efficacy as a generic medication [1]